dihexa human studies Growth factors and their peptide mimetics for treatment of traumatic brain injury DIHEXA is changing the conversation

132 , 133 , 135 Thus, for BPC 157 application as a cytoprotective agent, we could likely envisage an analogy with the counteraction of the stomach lesion induced by NSAIDs much like the counteraction of all others adverse of NSAIDs effects, including the central disturbances

30-45 , , , ,

I know some people will debate it, but it seems like there are enough people walking around who were vaccinated and non vaccinated who claim that they have symptoms post Covid that have lasted a long time, AKA long Covid

Treatment plans do vary, so we will advise on this at consultation, after any testing and discussion of your individual requirements

A study in 2007 by Marinoni et al discovered a novel vasoactive peptide, adrenomedullin